General Information of the Compound
Compound ID
CP0405472
Compound Name
(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-4-methylpentanoic acid
    Show/Hide
Synonyms
(S)-2-{(2S,3R)-2-[(S)-2-({(S)-1-[(S)-2-((S)-2-Amino-5-guanidino-pentanoylamino)-5-guanidino-pentanoyl]-pyrrolidine-2-carbonyl}-amino)-3-(4-hydroxy-phenyl)-propionylamino]-3-methyl-pentanoylamino}-4-methyl-pentanoic acid
2-{(S)-2-[2-({(S)-1-[(S)-2-((S)-2-Amino-5-guanidino-pentanoylamino)-5-guanidino-pentanoyl]-pyrrolidine-2-carbonyl}-amino)-3-(4-hydroxy-phenyl)-propionylamino]-3-methyl-pentanoylamino}-4-(S)-methyl-pentanoic acid
BDBM50240845
CHEMBL342252
Neurotensin(8-13)
    Show/Hide
Structure
Formula
C38H64N12O8
Molecular Weight
817.006
Canonical SMILES
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O
    Show/Hide
InChI
InChI=1S/C38H64N12O8/c1-5-22(4)30(34(55)48-28(36(57)58)19-21(2)3)49-32(53)27(20-23-12-14-24(51)15-13-23)47-33(54)29-11-8-18-50(29)35(56)26(10-7-17-45-38(42)43)46-31(52)25(39)9-6-16-44-37(40)41/h12-15,21-22,25-30,51H,5-11,16-20,39H2,1-4H3,(H,46,52)(H,47,54)(H,48,55)(H,49,53)(H,57,58)(H4,40,41,44)(H4,42,43,45)/t22-,25-,26-,27-,28-,29-,30-/m0/s1
    Show/Hide
InChIKey
DQDBCHHEIKQPJD-ODKJCKIQSA-N
Physicochemical Property
logP
-1.10446
Rotatable Bonds
24
Heavy Atom Count
58
Polar Areas
344.06
Hydrogen Bond Donor Count
13
Hydrogen Bond Acceptor Count
10
Complexity
58

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 5311318
SID: 14816016
ChEMBL ID
CHEMBL415788
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02429, Neurotensin receptor type 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000011 CHO Cricetulus griseus (Chinese hamster)  2
1
EC50 = 0.0416 nM
   TI
   LI
   LO
   TS
2
EC50 = 0.06918 nM
   TI
   LI
   LO
   TS
CL000006 HEK293 Homo sapiens (Human)  1
1
EC50 = 0.15 nM
   TI
   LI
   LO
   TS
CL000026 CHO-K1 Cricetulus griseus (Chinese hamster)  10
1
EC50 = 0.4 nM
   TI
   LI
   LO
   TS
2
EC50 = 0.6 nM
   TI
   LI
   LO
   TS
3
EC50 = 1.42 nM
   TI
   LI
   LO
   TS
4
EC50 = 1.85 nM
   TI
   LI
   LO
   TS
5
IC50 = 0.8 nM
   TI
   LI
   LO
   TS
6
IC50 = 0.82 nM
   TI
   LI
   LO
   TS
7
Ki = 0.24 nM
   TI
   LI
   LO
   TS
8
Ki = 0.9 nM
   TI
   LI
   LO
   TS
9
Ki = 1.07 nM
   TI
   LI
   LO
   TS
10
Ki = 1.29 nM
   TI
   LI
   LO
   TS
CL000007 HT-29 Homo sapiens (Human)  3
1
EC50 = 1.202 nM
   TI
   LI
   LO
   TS
2
Ki = 0.1288 nM
   TI
   LI
   LO
   TS
3
Ki = 0.33 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Ki = 0.24 nM
Protein ID: PT02626, Neurotensin receptor type 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000094 1321N1 Homo sapiens (Human)  3
1
IC50 = 7.52 nM
   TI
   LI
   LO
   TS
2
Ki = 0.55 nM
   TI
   LI
   LO
   TS
3
Ki = 6.57 nM
   TI
   LI
   LO
   TS
CL000006 HEK293 Homo sapiens (Human)  2
1
Ki = 0.7413 nM
   TI
   LI
   LO
   TS
2
Ki = 1.2 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( Neurotensin(8-13) )
Drug Name Neurotensin(8-13)
Target(s)
Neurotensin receptor type 1 (NTSR1)
Inhibitor